October 04, 2024

Diabetes, Obesity Could Raise Long-Term HCC Recurrence Risk

Patients with both obesity and diabetes saw a 2.53-fold increase in hepatocellular carcinoma recurrence beyond five years post-surgery, highlighting the critical impact of these comorbidities on long-term outcomes.

Conexiant

September 27, 2024

Over 3,600 Food Contact Chemicals Found in Humans

Eighty FCCs had properties that warrant further investigation for potential health concerns, such as carcinogenic, mutagenic, and reproductive toxicity.

Conexiant

September 23, 2024

Bleeding Disorders Meet Liver Care: New Guidelines

New multi-society guidelines tackle the complex intersection of congenital bleeding disorders and liver disease management, addressing a historically high-risk patient population.

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

August 14, 2024

U.S. Adults’ Exposure to 6 Potentially Hepatotoxic Botanicals

A recent study found that approximately 15.6 million U.S. adults may be using botanicals with known liver toxicity, raising concerns about potential hepatotoxic risks and the lack of regulatory oversight.

Conexiant

May 02, 2024

Preclinical Findings Could Lay Groundwork for Eliminating Chronic HBV Infections

Hepatitis B virus (HBV)-specific human stem cell memory T cells may be effective remedial therapy in patients with chronic HBV infection.

Conexiant

July 25, 2024

Hepatic Encephalopathy May Masquerade as Dementia

Hepatic encephalopathy might be misdiagnosed as dementia or cause worsening of cognitive function in patients with dementia.

Conexiant

June 05, 2024

Noncompete Ban May Not Help Nonprofit Workers

Health care professionals welcome the FTC's new rule banning noncompete agreements but are concerned it may not protect those in nonprofit health care settings, potentially impacting most of the nation's medical professionals.

KFF Health News

July 16, 2024

Combo Therapy Shows Promise for Chronic Hepatitis D

Trial reveals promising combination therapy for chronic hepatitis D, offering potential for sustained virologic response without indefinite treatment.

Conexiant